epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Camcevi
    leuprolide
  • remove Ponvory
    ponesimod
  • remove Symbravo
    meloxicam/ rizatriptan

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Camcevi (leuprolide) + Ponvory (ponesimod)

Avoid/Use Alternative


leuprolide + ponesimod

PROSTATE CANCER: use alternative or monitor HR, ECG, electrolytes; ALL OTHER INDICATIONS: consider monitoring ECG, electrolytes: combo may incr. risk of bradycardia, AV block, QT prolongation, cardiac arrhythmias (additive effects, androgen deprivation may prolong QT)

Monitor/Modify Tx

Smiley face Smiley face Ponvory (ponesimod) + Symbravo (meloxicam/ rizatriptan)

Monitor/Modify Tx


ponesimod + meloxicam

monitor BP: combo may incr. risk of HTN (additive effects)

ponesimod + rizatriptan

monitor BP: combo may incr. risk of HTN (additive effects)

Additional Considerations

Smiley face Smiley face rizatriptan in Symbravo

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information